Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comparative Trials Urged By NEJM Departing Editor To Deter "Me-Too" Drugs

Executive Summary

FDA should make new drug approvals based on comparisons to existing therapies in order to stem the tide of "me-too" medications being brought to market, New England Journal of Medicine Editor-In-Chief Marcia Angell, MD, said in the journal's June 22 issue.

You may also be interested in...



BMS Counting On Initial Combo Use For Glucovance To Supplant Glucophage

Bristol-Myers Squibb's Glucovance (metformin/glyburide) is emerging from FDA in time to give Bristol a half a year or more to transfer the market from its $1.9 bil. single-agent product Glucophage to the new combo.

BMS Counting On Initial Combo Use For Glucovance To Supplant Glucophage

Bristol-Myers Squibb's Glucovance (metformin/glyburide) is emerging from FDA in time to give Bristol a half a year or more to transfer the market from its $1.9 bil. single-agent product Glucophage to the new combo.

Drug Pricing Strategies To Be Discussed At HHS Drug Conference In August

The pharmaceutical industry's methods for arriving at drug prices will be considered at an HHS conference in August.

Related Content

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel